UK Markets close in 5 hrs 19 mins

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.75-0.87 (-5.95%)
At close: 4:00PM EDT

13.10 -0.65 (-4.73%)
Before hours: 6:09AM EDT

Full screen
Trade prices are not sourced from all markets
Previous close14.62
Open14.96
Bid0.00 x 1400
Ask13.10 x 1000
Day's range12.41 - 15.19
52-week range1.92 - 33.79
Volume35,602,648
Avg. volume35,481,673
Market cap2.303B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Robinhood Traders Love These 2 Coronavirus Vaccine Stocks, But Should You?
    Motley Fool

    Robinhood Traders Love These 2 Coronavirus Vaccine Stocks, But Should You?

    If you've been following the race to discover a coronavirus vaccine, it won't be any shock to hear that both Moderna Therapeutics (NASDAQ: MRNA) and Inovio Pharmaceuticals (NASDAQ: INO) are among the top 100 most-traded stocks on Robinhood. Between their vigorous price movements in the last five months and their consistently advancing vaccine programs, each company's market cap has ballooned to unpredictable heights far in excess of the pre-pandemic norms. While these minor quibbles might not be very convincing to Robinhood traders, if you're evaluating these two stocks for a long-term portfolio, it's critical to understand which investing metrics to monitor and why so you can make an informed decision.

  • Why Inovio Stock Is Sinking Again Today
    Motley Fool

    Why Inovio Stock Is Sinking Again Today

    Shares of Inovio Pharmaceuticals (NASDAQ: INO) were sinking 12.2% lower as of 11:16 a.m. EDT on Wednesday. This marked the second consecutive day of steep declines for the stock after Inovio's Q2 update on Monday evening didn't provide as much detail about the clinical results of its COVID-19 vaccine candidate INO-4800 as analysts wanted. The core issue for Inovio is the skepticism about just how effective INO-4800 will be in protecting against the coronavirus that causes COVID-19.

  • Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine Concerns
    Motley Fool

    Stock Markets Take Late-Day Hit; Inovio, Novavax Plunge on Coronavirus Vaccine Concerns

    On Wall Street, it seemed as though Tuesday would be a repeat of Monday, with strength in the Dow Jones Industrial Average (DJINDICES: ^DJI) coupled with weakness in the tech-heavy Nasdaq Composite. Shares of Novavax were down 16% Tuesday.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more